DK1589014T3 - Fremgangsmåde til syntese af derivater af 1,3-dihydro-2H-3-benzazepin-2-on og anvendelse heraf ved syntese af ivabradin og additionssalte heraf med en farmaceutisk acceptabel syre - Google Patents

Fremgangsmåde til syntese af derivater af 1,3-dihydro-2H-3-benzazepin-2-on og anvendelse heraf ved syntese af ivabradin og additionssalte heraf med en farmaceutisk acceptabel syre

Info

Publication number
DK1589014T3
DK1589014T3 DK05290382T DK05290382T DK1589014T3 DK 1589014 T3 DK1589014 T3 DK 1589014T3 DK 05290382 T DK05290382 T DK 05290382T DK 05290382 T DK05290382 T DK 05290382T DK 1589014 T3 DK1589014 T3 DK 1589014T3
Authority
DK
Denmark
Prior art keywords
synthesis
ivabradine
benzazepin
dihydro
derivatives
Prior art date
Application number
DK05290382T
Other languages
English (en)
Inventor
Jean-Michel Lerestif
Jean-Pierre Lecouve
Daniel Brigot
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1589014T3 publication Critical patent/DK1589014T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK05290382T 2004-04-13 2005-02-21 Fremgangsmåde til syntese af derivater af 1,3-dihydro-2H-3-benzazepin-2-on og anvendelse heraf ved syntese af ivabradin og additionssalte heraf med en farmaceutisk acceptabel syre DK1589014T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0403829A FR2868776B1 (fr) 2004-04-13 2004-04-13 Nouveau procede de synthese de derives de la 1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Publications (1)

Publication Number Publication Date
DK1589014T3 true DK1589014T3 (da) 2008-02-25

Family

ID=34941960

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05290382T DK1589014T3 (da) 2004-04-13 2005-02-21 Fremgangsmåde til syntese af derivater af 1,3-dihydro-2H-3-benzazepin-2-on og anvendelse heraf ved syntese af ivabradin og additionssalte heraf med en farmaceutisk acceptabel syre

Country Status (33)

Country Link
US (1) US7074920B2 (da)
EP (1) EP1589014B1 (da)
JP (2) JP4511970B2 (da)
KR (1) KR100636500B1 (da)
CN (1) CN1332951C (da)
AR (1) AR047686A1 (da)
AT (1) ATE375339T1 (da)
AU (1) AU2005200860B2 (da)
BR (1) BRPI0500478B8 (da)
CA (1) CA2496721C (da)
CY (1) CY1107101T1 (da)
DE (1) DE602005002776T2 (da)
DK (1) DK1589014T3 (da)
EA (1) EA007744B1 (da)
ES (1) ES2294652T3 (da)
FR (1) FR2868776B1 (da)
GE (1) GEP20074137B (da)
HK (1) HK1079776A1 (da)
HR (1) HRP20070503T3 (da)
MA (1) MA27599A1 (da)
ME (1) ME01402B (da)
MX (1) MXPA05003695A (da)
MY (1) MY141223A (da)
NO (1) NO329438B1 (da)
NZ (1) NZ538327A (da)
PL (1) PL1589014T3 (da)
PT (1) PT1589014E (da)
RS (1) RS50546B (da)
SG (1) SG116573A1 (da)
SI (1) SI1589014T1 (da)
UA (1) UA81772C2 (da)
WO (1) WO2005111026A1 (da)
ZA (1) ZA200501467B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868776B1 (fr) * 2004-04-13 2008-04-18 Servier Lab Nouveau procede de synthese de derives de la 1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
JP5632279B2 (ja) 2007-05-30 2014-11-26 アイエヌディー−スイフト ラボラトリーズ リミテッド 塩酸イバブラジンの調製方法及びポリモルフ
WO2010072409A1 (en) 2008-12-22 2010-07-01 Krka, D. D., Novo Mesto Process for preparation of ivabradine
SI23290A (sl) 2010-02-12 2011-08-31 Krka D.D., Novo Mesto Nove oblike ivabradin hidroklorida
FR2956401B1 (fr) * 2010-02-17 2012-02-03 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2984320B1 (fr) * 2011-12-20 2013-11-29 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4490369A (en) * 1981-05-19 1984-12-25 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Benzazepine derivatives, their pharmaceutical compositions and method of use
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
DE3242599A1 (de) * 1982-11-18 1984-05-24 Dr. Karl Thomae Gmbh, 7950 Biberach Neue benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel
DE3418270A1 (de) * 1984-05-17 1985-11-21 Dr. Karl Thomae Gmbh, 7950 Biberach Neue aminotetralinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3519735A1 (de) * 1985-06-01 1986-12-04 Dr. Karl Thomae Gmbh, 7950 Biberach Neue heteroaromatische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0204349A3 (de) * 1985-06-01 1990-01-03 Dr. Karl Thomae GmbH Neue heteroaromatische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE3717561A1 (de) * 1987-05-25 1988-12-08 Thomae Gmbh Dr K Indol-, isochinolin- und benzazepinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
JP2568416B2 (ja) * 1986-11-04 1997-01-08 大塚製薬株式会社 ヒドロフルオレン誘導体
JPH0495078A (ja) * 1990-08-08 1992-03-27 Nippon Shoji Kk ピリミドン誘導体の製造法、そのための中間体
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
TW279860B (da) * 1993-11-12 1996-07-01 Ciba Geigy Ag
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868776B1 (fr) * 2004-04-13 2008-04-18 Servier Lab Nouveau procede de synthese de derives de la 1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Also Published As

Publication number Publication date
WO2005111026A1 (fr) 2005-11-24
PT1589014E (pt) 2007-12-13
UA81772C2 (uk) 2008-02-11
GEP20074137B (en) 2007-06-25
ZA200501467B (en) 2005-11-30
JP2010043096A (ja) 2010-02-25
SI1589014T1 (sl) 2008-02-29
KR20060042120A (ko) 2006-05-12
JP4511970B2 (ja) 2010-07-28
EP1589014A1 (fr) 2005-10-26
US7074920B2 (en) 2006-07-11
AU2005200860B2 (en) 2010-08-05
CN1683342A (zh) 2005-10-19
PL1589014T3 (pl) 2008-01-31
FR2868776B1 (fr) 2008-04-18
FR2868776A1 (fr) 2005-10-14
MA27599A1 (fr) 2005-11-01
ES2294652T3 (es) 2008-04-01
AU2005200860A1 (en) 2005-10-27
CA2496721A1 (fr) 2005-10-13
AR047686A1 (es) 2006-02-01
BRPI0500478B1 (pt) 2019-04-02
HRP20070503T3 (en) 2007-12-31
US20050227962A1 (en) 2005-10-13
NO329438B1 (no) 2010-10-18
BRPI0500478A (pt) 2005-11-16
SG116573A1 (en) 2005-11-28
DE602005002776D1 (de) 2007-11-22
BRPI0500478B8 (pt) 2021-05-25
NZ538327A (en) 2005-11-25
EP1589014B1 (fr) 2007-10-10
MY141223A (en) 2010-03-31
EA200500237A1 (ru) 2005-10-27
CN1332951C (zh) 2007-08-22
RS50546B (sr) 2010-05-07
DE602005002776T2 (de) 2008-08-28
ATE375339T1 (de) 2007-10-15
NO20050885L (no) 2005-10-14
NO20050885D0 (no) 2005-02-18
MXPA05003695A (es) 2006-01-24
ME01402B (me) 2010-05-07
CA2496721C (fr) 2010-09-07
HK1079776A1 (en) 2006-04-13
KR100636500B1 (ko) 2006-10-18
CY1107101T1 (el) 2012-10-24
EA007744B1 (ru) 2006-12-29
JP2005298479A (ja) 2005-10-27

Similar Documents

Publication Publication Date Title
DK1589005T3 (da) Fremgangsmåde til syntese af ivabradin og additionssalte heraf med en farmaceutisk acceptabel syre
NO20050883D0 (no) Ny fremgangsmate for syntesen (IS)-4,5-dimetoksy-1-(metylaminometyl)-benzocyklobutan og addisjonssalter derav, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
DK1614687T3 (da) Fremgangsmåde til fremstilling af 1,3,4,5-tetrahydro-2H-3-benzazepin-2-onderivater og deres anvendelse ved syntese af ivabradin og farmaceutisk acceptable salte deraf
DK2135861T3 (da) Fremgangsmåde til syntese af 7,8-dimethoxy-1,3-dihydro-2H-3-benzazepin-2-on og dets anvendelse ved syntese af ivabradin såvel som dets additionssalte med en farmaceutisk acceptabel syre
IL179424A0 (en) Substituted oxazole -benzoisothiazole dioxide derivatives, process for their preparation and their use
EP1876169A4 (en) PHENYL-CONTAINING N-ACYLAMINE AND AMINO ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, A PHARMACEUTICAL COMPOSITION AND THE APPLICATION THEREOF
DK1589014T3 (da) Fremgangsmåde til syntese af derivater af 1,3-dihydro-2H-3-benzazepin-2-on og anvendelse heraf ved syntese af ivabradin og additionssalte heraf med en farmaceutisk acceptabel syre
SI1994005T1 (sl) Tetrahidronaftalenski derivati postopek za njihovo pripravo in njihova uporaba kot protivnetna sredstva
PL1753720T3 (pl) Proces wytwarzania peryndoprylu i jego soli
IL188260A0 (en) 6-oxazol-4-ylmethoxy-alkoxymethyl substituted benzoic acid derivatives forming ppar ligands, methods for production and the use thereof in the form of drugs
DE602004012275D1 (de) zu dessen Herstellung und Impstoffderivate davon
GB0807094D0 (en) 4,4-dimethylpiperidine-2, 6-dione derivatives for use in the treatment of hypertension
SG117528A1 (en) New process for the synthesis of (1S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane and addition salts thereof, and application in the synthesis of ivabradine and addition salts thereof, with
WO2008005955A3 (en) Synthesis of heterocyclic compounds